EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiota-derived metabolites in keloid and hypertrophic scarring

Junjie Jin, Zhenlong Zheng

Frontiers in Microbiology · 05.09.2025 · 16

DOI: 10.3389/fmicb.2025.1644758 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 05.09.2025. Verfasst von Junjie Jin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yanbian University Hospital, Jilin, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keloids and hypertrophic scars are fibro-proliferative skin disorders that arise from aberrant wound healing and are characterized by excessive collagen deposition and chronic inflammation. Although traditionally viewed as strictly local cutaneous phenomena, growing evidence suggests that systemic influences—particularly the gut microbiota and its metabolites—may influence scar pathogenesis. The gut microbiota produces a wide range of bioactive compounds, including short-chain fatty acids (SCFAs), bile acids, and tryptophan derivatives, which are hypothesized to modulate immune responses and pro-fibrotic signaling pathways such as TGF- β and Wnt/β-catenin. Observations from systemic fibrotic disorders—for example, liver and pulmonary fibrosis—link microbial dysbiosis to aberrant extracellular-matrix remodeling. Although direct evidence in skin fibrosis is still limited, recent multi-omics analyses and microbiota-transplantation studies imply that gut-derived factors may influence dermal fibroblast behavior. This review therefore synthesizes the emerging conceptual and mechanistic connections between gut microbial metabolites and pathological scar formation, proposes a possible skin-gut-fibrosis axis, and outlines potential avenues for therapeutic intervention in keloids and hypertrophic scars.

Schlagwörter

Stichwörter der Autor:innen

gut microbiomeimmunomodulationmicrobiome therapiespathological scarringskin–gut axis

Autor:innen und Institutionen

  • Department of Dermatology, Yanbian University Hospital, Jilin, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jin, J., & Zheng, Z. (2025). Gut microbiota-derived metabolites in keloid and hypertrophic scarring. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1644758

Vancouver

Jin J, Zheng Z. Gut microbiota-derived metabolites in keloid and hypertrophic scarring. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1644758

BibTeX
@article{Jin2025,
  author = {Jin, Junjie and Zheng, Zhenlong},
  title = {Gut microbiota-derived metabolites in keloid and hypertrophic scarring},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1644758}
}
Kostenlos starten →